Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study
The fair synthesis is that cagrilintides effect on human gastric emptying is inferred with moderate confidence from mechanism and side-effect data, but not precisely quantified over time in published monotherapy trials
This is not a complete list of risks or precautions, and it does not replace the guidance of your prescribing clinician
However, for the vast majority of patients, access to brand-name semaglutide (sold as Wegovy for weight loss and Ozempic for type 2 diabetes by Novo Nordisk) is blocked by a single, massive hurdle: cost
Common Side Effects and Warnings The most reported adverse effects are gastrointestinalnausea, vomiting, diarrhea, or constipationespecially during dose escalation